81 related articles for article (PubMed ID: 32156714)
1. Prevalence and predictors of HIV screening in invasive cervical cancer: a 10 year cohort study.
Alldredge J; Leaf MC; Patel P; Coakley K; Longoria T; McLaren C; Randall LM
Int J Gynecol Cancer; 2020 Jun; 30(6):772-776. PubMed ID: 32156714
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus seroprevalence in patients with invasive cervical cancer in Zaria, North-Western Nigeria.
Abdullahi A; Mustapha MI; David DA; Ayodeji OT
Ann Afr Med; 2018; 17(1):17-21. PubMed ID: 29363631
[TBL] [Abstract][Full Text] [Related]
3. Patients with AIDS-defining cancers are not universally screened for HIV: a 10-year retrospective analysis of HIV-testing practices in a Swiss university hospital.
Mosimann V; Cavassini M; Hugli O; Mamin R; Achtari C; Peters S; Darling KE
HIV Med; 2014 Nov; 15(10):631-4. PubMed ID: 25102762
[TBL] [Abstract][Full Text] [Related]
4. HIV infection and invasive cervical carcinoma in an Italian population: the need for closer screening programmes in seropositive patients.
Zanetta G; Maneo A; Colombo A; Ragusa A; Gabriele A; Placa F; Mangioni C
AIDS; 1995 Aug; 9(8):909-12. PubMed ID: 7576326
[TBL] [Abstract][Full Text] [Related]
5. Knowledge, attitudes, and practices of cervical Cancer screening among HIV-positive and HIV-negative women participating in human papillomavirus screening in rural Zimbabwe.
Fitzpatrick M; Pathipati MP; McCarty K; Rosenthal A; Katzenstein D; Chirenje ZM; Pinsky B
BMC Womens Health; 2020 Jul; 20(1):153. PubMed ID: 32711530
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and correlates of cervical cancer screening among injection drug users.
McKnight B; McKnight I; Kerr T; Li K; Montaner J; Wood E
J Obstet Gynaecol Can; 2006 Aug; 28(8):695-699. PubMed ID: 17022909
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus.
Goldie SJ; Freedberg KA; Weinstein MC; Wright TC; Kuntz KM
Am J Med; 2001 Aug; 111(2):140-9. PubMed ID: 11498068
[TBL] [Abstract][Full Text] [Related]
9. Patterns of HIV testing among women diagnosed with invasive cervical cancer in the New Jersey Medicaid Program.
McGee-Avila JK; Doose M; Nova J; Kumar R; Stroup AM; Tsui J
Cancer Causes Control; 2020 Oct; 31(10):931-941. PubMed ID: 32803402
[TBL] [Abstract][Full Text] [Related]
10. Integrating Cervical Cancer Screening Into Safer Conception Services to Improve Women's Health Outcomes: A Pilot Study at a Primary Care Clinic in South Africa.
Davies NECG; Chersich M; Mullick S; Naidoo N; Makhoba N; Rees H; Schwartz SR
Sex Transm Dis; 2019 Feb; 46(2):91-97. PubMed ID: 30308532
[TBL] [Abstract][Full Text] [Related]
11. Squamous intraepithelial lesions of the cervix, invasive cervical carcinoma, and immunosuppression induced by human immunodeficiency virus in Africa. Dyscer-CI Group.
La Ruche G; Ramon R; Mensah-Ado I; Bergeron C; Diomandé M; Sylla-Koko F; Ehouman A; Touré-Coulibaly K; Welffens-Ekra C; Dabis F
Cancer; 1998 Jun; 82(12):2401-8. PubMed ID: 9635533
[TBL] [Abstract][Full Text] [Related]
12. Predictors of compliance with recommended cervical cancer screening schedule: a population-based study.
Simoes EJ; Newschaffer CJ; Hagdrup N; Ali-Abarghoui F; Tao X; Mack N; Brownson RC
J Community Health; 1999 Apr; 24(2):115-30. PubMed ID: 10202691
[TBL] [Abstract][Full Text] [Related]
13. Disproportionate high incidence of invasive cervical cancer as an AIDS-indicative disease among young women in Catalonia, Spain.
Mayans MV; Maguire A; Miret M; Casabona J
Sex Transm Dis; 1999 Oct; 26(9):500-3. PubMed ID: 10534202
[TBL] [Abstract][Full Text] [Related]
14. HIV infection and invasive cervical cancers, treatment with radiation therapy: toxicity and outcome.
Shrivastava SK; Engineer R; Rajadhyaksha S; Dinshaw KA
Radiother Oncol; 2005 Jan; 74(1):31-5. PubMed ID: 15683666
[TBL] [Abstract][Full Text] [Related]
15. Is HIV infection a risk factor for advanced cervical cancer?
Fruchter RG; Maiman M; Arrastia CD; Matthews R; Gates EJ; Holcomb K
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jul; 18(3):241-5. PubMed ID: 9665501
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the scale-up of cervical cancer screening in Abidjan stratified by HIV status.
Boni S; Tchounga B; Comoe K; Guie P; Adié M; Horo A; Messou E; Ekouévi DK; Dabis F; Adoubi I; Jaquet A
Int J Gynaecol Obstet; 2019 Nov; 147(2):246-251. PubMed ID: 31482577
[TBL] [Abstract][Full Text] [Related]
17. HIV Testing in Patients With Cancer at the Initiation of Therapy at a Large US Comprehensive Cancer Center.
Hwang JP; Granwehr BP; Torres HA; Suarez-Almazor ME; Giordano TP; Barbo AG; Lin HY; Fisch MJ; Chiao EY
J Oncol Pract; 2015 Sep; 11(5):384-90. PubMed ID: 26243649
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus infection and cervical neoplasia.
Maiman M; Fruchter RG; Serur E; Remy JC; Feuer G; Boyce J
Gynecol Oncol; 1990 Sep; 38(3):377-82. PubMed ID: 2227552
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.
ter Meulen J; Eberhardt HC; Luande J; Mgaya HN; Chang-Claude J; Mtiro H; Mhina M; Kashaija P; Ockert S; Yu X
Int J Cancer; 1992 Jun; 51(4):515-21. PubMed ID: 1318265
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus genotype distribution and human papillomavirus 16 and human papillomavirus 18 genomic integration in invasive and in situ cervical carcinoma in human immunodeficiency virus-infected women.
Darwich L; Cañadas MP; Sirera G; Alameda F; Forcada P; Delas J; Fernández I; Llatjós M; Coll J; Clotet B; Videla S
Int J Gynecol Cancer; 2011 Nov; 21(8):1486-90. PubMed ID: 21892092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
